headquarters in new york city, a huge turnaround, the cook political report has new analysis showing it s a toss-up. that s a pretty stunning shift from months ago, where headline after headline predicted a republican wave. thanks to a string of legislative wins and galvanizing issues like abortion, democrats now have motivation and momentum on their side. on the other side, many far-right republicans are struggling, unable to connect with moderate i m at wegner s. my wife wants some vegetables for crudite. this is $20, and we have joe biden to thank for this. john fetterman has been fund-raising off that video all week. this is the kind of thing that mitch mcconnell to admit he has concerns. i think there s a greater likelihood that the house flips than the senate. senate races are different. they re statewide. candidate quality has a lot to do with the outcome. looking at various numbers, you can see the shift happening in real time. politico shows democrats up fo
that s been peer reviewed. the strength of the data is as strong as the data that that allows subcutaneous immunization. so we re confidence it will 23407b8 provide protection, but extend the number of arms that can vaccine in them. it s a win-win. it s also important to remember we re monitoring what s happening. so through vaccine effectiveness studies, as well as surveillance we ll keep close dibs on what is happening. i presume that also includes not just the efficaciousness of it, but also the efficacy of it, but also who is getting it. new york has releasing new data showing spark disparities in access, black men receiving the vaccine at a much lower rate. what are you doing to close that gap? convene is one of our top
college of medicine as i m sure moderna and pfizer is. you take serum from an experimental animal or serum from patients who have been vaccinated and you first confirm that it s neutralizing the original variant, which you d expect, and then you look at the decline in virus neutralizing antibodies against the omicron variant as well as some of the others. undoubtedly the moderna ceo is right, there will be a decline. i still have optimism that it may hold up sufficiently to cause significant protection, but it s all moot. we ll know this in a week or so and those are going to be important studies. i was just going to say this is a knowable answer before the end of next week? possibly. and again, this is not the same as looking at actual vaccine effectiveness studies in the field. it s still a laboratory-based observation. but it gives us a trend and a hint of what we re dealing with.
of a third dose. and cdc scientists are expected to present vaccine effectiveness studies. on tuesday, we also learned some promising news about a different company s vaccine. cnn s jason carroll has more. reporter: an encouraging development for the nearly 15 million americans who have received the johnson & johnson vaccine. the company now says that adding a second dose of the shot provides 94% protection against symptomatic infections. it s a big day for pfizer as well. fda authorization on their booster shot for some people could be coming at any moment. this as it looks more and more likely the pfizer vaccine for children ages 5 to 11 could come as soon as halloween. we ve had 225,000 kids with covid. it s a serious issue among children, and the best way to protect them is with this
ONA
2) found the employer s policy
compliant, citing provisions of the collective agreement that
specifically addressed vaccinations during an outbreak, directions
from the Ministry of Health to employers to implement an influenza
protocol, expert evidence supporting vaccination rates amongst
health care workers and transmission of influenza to the patients,
and the existence of the alternative of masking. In other decisions
(see
Sault Area Hospital and Ontario Nurses
Association
3,
4 and
v Ontario Nurses
Association
5), arbitrators found the policy in
violation of the collective agreement citing a lack of consensus on vaccinating and masking and the prevention
and control of influenza, a lack of mandating of the policy by a